CCL2 and central nervous system neoplasm: The correlation of more severe TIAN with higher levels of cytokines/chemokines related to myeloid response, such as MCP1 or CCL2, raises the prospect that myeloid cells may contribute to neurological symptoms induced by CAR T cell therapy for CNS tumours, a hypothesis that requires testing in future studies.